Section 25.115. Registration fees

(a) General. This subsection lists annual registration fees, applicable late registration fees, and compulsory registration fees. All late fees shall accrue on a calendar month basis, the amount to be determined by multiplying the appropriate fee by the number of months—any portion of a month shall be considered a full month—by which the registrant is late. The late fee will commence from the month a manufacturer, distributor, or retailer has been notified they are not registered as required by law. The compulsory registration fees listed in subsection (d) are in addition to the fees listed in subsections (b) and (c). They shall apply to any of the unregistered categories upon the filing of any lawsuit to compel compliance with the registration requirements of the act.

(b) Fees for controlled substances and nonproprietary drugs. The fees for manufacturing or distributing controlled substances and nonproprietary drugs are as follows:

(1)	Manufacturer	—Annual Fee	$400
		—Late Fee	$50
(2)	Distributor	—Annual Fee	$100
		—Late Fee	$10

(c) Fees for other drugs. The fees for manufacturing, distributing, or retailing other drugs are as follows:

(1)	Manufacturer	—Annual Fee	$100
		—Late Fee	$25
(2)	Distributor	—Annual Fee	$25
		—Late Fee	$5.00
(3)	Retailer	—Annual Fee	$10
		—Late Fee	$2.00

(d) Fees for devices. The fees for manufacturing, distributing, or retailing devices for those persons not registered under subsections (b) or (c) are as follows:

(1)	Annual Fee	$25.
(2)	Late fee	$10.

(e) Compulsory registration fees. In the event that litigation is required to enforce the registration requirements of the act, the additional following compulsory registration fee shall apply for all categories of establishments listed in this section:

$250.

(f) Only the single highest fee will apply at a given location.

(g) Such fees shall not be required of organizations which qualify for exemption under section 501(c)(3) of the Internal Revenue Code of 1954 as amended, 26 U.S.C.A. § 501(c)(3).

The provisions of this § 25.115 amended through November 4, 1983, effective January 4, 1984, 13 Pa.B 3375. Immediately preceding text appears at serial pages (59705) and (59706).

Notation

Authority

The provisions of this § 25.115 issued under sections 6 and 25 of the Controlled Substance, Drug, Device and Cosmetic Act (35 P. S. § § 780-106 and 780-135); and section 2102(g) of The Administrative Code of 1929 (71 P. S. § 532(g)).